Dr. Brian Matlaga is Assistant Professor of Urology at The Brady Urological Institute and the Director of Stone Disease at Johns Hopkins Bayview Medical Center. Dr. Matlaga came to Johns Hopkins after completing a fellowship in minimally invasive surgery and metabolic stone disease. During his fellowship he was designated an American Foundation for Urologic Disease Research Scholar, and was awarded the Outstanding Research Scholar honor in recognition of his work involving the treatment of patients with stone disease.

More recently, his work to define the pathophysiology of calcium oxalate stone disease won the Best Overall Paper Award at the 24th Annual World Congress of Endourology.

Dr. Matlaga’s main clinical interest is the minimally invasive treatment of patients with metabolic stone disease, including percutaneous nephrolithotomy, ureteroscopy, and shock wave lithotripsy. In addition, Dr. Matlaga has an interest in the holmium laser enucleation of the prostate (HoLEP), a minimally invasive laser therapy for men with benign prostatic enlargement.

As the Director of Stone Disease, Dr. Matlaga is actively engaged in clinical and basic science research addressing the questions of: Which patients develop stones? How do stones form? How well are we treating patients with stones?